ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Targeted Chemotherapy Drugs Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-22H16787
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Targeted Chemotherapy Drugs Market Research Report 2024
BUY CHAPTERS

Global Targeted Chemotherapy Drugs Market Research Report 2026

Code: QYRE-Auto-22H16787
Report
2026-04-18
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Celgene
Bristol–Myers Squibb
Takeda
Seekyo

Targeted Chemotherapy Drugs Market

The global Targeted Chemotherapy Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Targeted Chemotherapy Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Targeted Chemotherapy Drugs are a class of medications designed to specifically target and attack cancer cells without affecting normal cells. They work by identifying and interfering with specific molecules involved in the growth, progression, and spread of cancer. These drugs can be considered a form of precision medicine, as they aim to match a patient’s individual genetic profile with an appropriate targeted therapy.
The North American market for Targeted Chemotherapy Drugs is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Targeted Chemotherapy Drugs is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Targeted Chemotherapy Drugs include Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Targeted Chemotherapy Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Targeted Chemotherapy Drugs. The Targeted Chemotherapy Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Targeted Chemotherapy Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Targeted Chemotherapy Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Targeted Chemotherapy Drugs Market Report

Report Metric Details
Report Name Targeted Chemotherapy Drugs Market
Segment by Type
  • Monoclonal Antibodies (MABs)
  • Cancer Growth Blockers
  • Angiogenesis Inhibitors
  • PARP Inhibitors
by Application
  • Breast Cancer Treatment
  • Lung Cancer Treatment
  • Gastric Cancer Treatment
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Targeted Chemotherapy Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Targeted Chemotherapy Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Targeted Chemotherapy Drugs Market report?

Ans: The main players in the Targeted Chemotherapy Drugs Market are Roche, Celgene, Bristol-Myers Squibb, Takeda, Seekyo

What are the Application segmentation covered in the Targeted Chemotherapy Drugs Market report?

Ans: The Applications covered in the Targeted Chemotherapy Drugs Market report are Breast Cancer Treatment, Lung Cancer Treatment, Gastric Cancer Treatment, Others

What are the Type segmentation covered in the Targeted Chemotherapy Drugs Market report?

Ans: The Types covered in the Targeted Chemotherapy Drugs Market report are Monoclonal Antibodies (MABs), Cancer Growth Blockers, Angiogenesis Inhibitors, PARP Inhibitors

1 Targeted Chemotherapy Drugs Market Overview
1.1 Product Definition
1.2 Targeted Chemotherapy Drugs by Type
1.2.1 Global Targeted Chemotherapy Drugs Market Value by Type: 2025 vs 2032
1.2.2 Monoclonal Antibodies (MABs)
1.2.3 Cancer Growth Blockers
1.2.4 Angiogenesis Inhibitors
1.2.5 PARP Inhibitors
1.3 Targeted Chemotherapy Drugs by Application
1.3.1 Global Targeted Chemotherapy Drugs Market Value by Application: 2025 vs 2032
1.3.2 Breast Cancer Treatment
1.3.3 Lung Cancer Treatment
1.3.4 Gastric Cancer Treatment
1.3.5 Others
1.4 Global Targeted Chemotherapy Drugs Market Size Estimates and Forecasts
1.4.1 Global Targeted Chemotherapy Drugs Revenue 2021–2032
1.4.2 Global Targeted Chemotherapy Drugs Sales 2021–2032
1.4.3 Global Targeted Chemotherapy Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Targeted Chemotherapy Drugs Market Competition by Manufacturers
2.1 Global Targeted Chemotherapy Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Targeted Chemotherapy Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Targeted Chemotherapy Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Targeted Chemotherapy Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Targeted Chemotherapy Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Targeted Chemotherapy Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Targeted Chemotherapy Drugs, Date of Entry into the Industry
2.8 Global Targeted Chemotherapy Drugs Market Competitive Situation and Trends
2.8.1 Global Targeted Chemotherapy Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Targeted Chemotherapy Drugs Players Market Share by Revenue
2.8.3 Global Targeted Chemotherapy Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Targeted Chemotherapy Drugs Market Scenario by Region
3.1 Global Targeted Chemotherapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Targeted Chemotherapy Drugs Sales by Region: 2021–2032
3.2.1 Global Targeted Chemotherapy Drugs Sales by Region: 2021–2026
3.2.2 Global Targeted Chemotherapy Drugs Sales by Region: 2027–2032
3.3 Global Targeted Chemotherapy Drugs Revenue by Region: 2021–2032
3.3.1 Global Targeted Chemotherapy Drugs Revenue by Region: 2021–2026
3.3.2 Global Targeted Chemotherapy Drugs Revenue by Region: 2027–2032
3.4 North America Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.4.1 North America Targeted Chemotherapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Targeted Chemotherapy Drugs Sales by Country (2021–2032)
3.4.3 North America Targeted Chemotherapy Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.5.1 Europe Targeted Chemotherapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Targeted Chemotherapy Drugs Sales by Country (2021–2032)
3.5.3 Europe Targeted Chemotherapy Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Targeted Chemotherapy Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Targeted Chemotherapy Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Targeted Chemotherapy Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Targeted Chemotherapy Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.7.1 Latin America Targeted Chemotherapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Targeted Chemotherapy Drugs Sales by Country (2021–2032)
3.7.3 Latin America Targeted Chemotherapy Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Targeted Chemotherapy Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Targeted Chemotherapy Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Targeted Chemotherapy Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Targeted Chemotherapy Drugs Sales by Type (2021–2032)
4.1.1 Global Targeted Chemotherapy Drugs Sales by Type (2021–2026)
4.1.2 Global Targeted Chemotherapy Drugs Sales by Type (2027–2032)
4.1.3 Global Targeted Chemotherapy Drugs Sales Market Share by Type (2021–2032)
4.2 Global Targeted Chemotherapy Drugs Revenue by Type (2021–2032)
4.2.1 Global Targeted Chemotherapy Drugs Revenue by Type (2021–2026)
4.2.2 Global Targeted Chemotherapy Drugs Revenue by Type (2027–2032)
4.2.3 Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Targeted Chemotherapy Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Targeted Chemotherapy Drugs Sales by Application (2021–2032)
5.1.1 Global Targeted Chemotherapy Drugs Sales by Application (2021–2026)
5.1.2 Global Targeted Chemotherapy Drugs Sales by Application (2027–2032)
5.1.3 Global Targeted Chemotherapy Drugs Sales Market Share by Application (2021–2032)
5.2 Global Targeted Chemotherapy Drugs Revenue by Application (2021–2032)
5.2.1 Global Targeted Chemotherapy Drugs Revenue by Application (2021–2026)
5.2.2 Global Targeted Chemotherapy Drugs Revenue by Application (2027–2032)
5.2.3 Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Targeted Chemotherapy Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Targeted Chemotherapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Roche Targeted Chemotherapy Drugs Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Celgene
6.2.1 Celgene Company Information
6.2.2 Celgene Description and Business Overview
6.2.3 Celgene Targeted Chemotherapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Celgene Targeted Chemotherapy Drugs Product Portfolio
6.2.5 Celgene Recent Developments/Updates
6.3 Bristol-Myers Squibb
6.3.1 Bristol-Myers Squibb Company Information
6.3.2 Bristol-Myers Squibb Description and Business Overview
6.3.3 Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bristol-Myers Squibb Targeted Chemotherapy Drugs Product Portfolio
6.3.5 Bristol-Myers Squibb Recent Developments/Updates
6.4 Takeda
6.4.1 Takeda Company Information
6.4.2 Takeda Description and Business Overview
6.4.3 Takeda Targeted Chemotherapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Takeda Targeted Chemotherapy Drugs Product Portfolio
6.4.5 Takeda Recent Developments/Updates
6.5 Seekyo
6.5.1 Seekyo Company Information
6.5.2 Seekyo Description and Business Overview
6.5.3 Seekyo Targeted Chemotherapy Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Seekyo Targeted Chemotherapy Drugs Product Portfolio
6.5.5 Seekyo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Targeted Chemotherapy Drugs Industry Chain Analysis
7.2 Targeted Chemotherapy Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Targeted Chemotherapy Drugs Production Mode & Process Analysis
7.4 Targeted Chemotherapy Drugs Sales and Marketing
7.4.1 Targeted Chemotherapy Drugs Sales Channels
7.4.2 Targeted Chemotherapy Drugs Distributors
7.5 Targeted Chemotherapy Drugs Customer Analysis
8 Targeted Chemotherapy Drugs Market Dynamics
8.1 Targeted Chemotherapy Drugs Industry Trends
8.2 Targeted Chemotherapy Drugs Market Drivers
8.3 Targeted Chemotherapy Drugs Market Challenges
8.4 Targeted Chemotherapy Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Celgene
Bristol–Myers Squibb
Takeda
Seekyo
List of Tables
 Table 1. Global Targeted Chemotherapy Drugs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Targeted Chemotherapy Drugs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Targeted Chemotherapy Drugs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Targeted Chemotherapy Drugs Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Targeted Chemotherapy Drugs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Targeted Chemotherapy Drugs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Targeted Chemotherapy Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Targeted Chemotherapy Drugs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Targeted Chemotherapy Drugs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Targeted Chemotherapy Drugs, Product Types and Applications
 Table 12. Global Key Manufacturers of Targeted Chemotherapy Drugs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Targeted Chemotherapy Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Targeted Chemotherapy Drugs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Targeted Chemotherapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Targeted Chemotherapy Drugs Sales by Region (K Units), 2021–2026
 Table 18. Global Targeted Chemotherapy Drugs Sales Market Share by Region (2021–2026)
 Table 19. Global Targeted Chemotherapy Drugs Sales by Region (K Units), 2027–2032
 Table 20. Global Targeted Chemotherapy Drugs Sales Market Share by Region (2027–2032)
 Table 21. Global Targeted Chemotherapy Drugs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Targeted Chemotherapy Drugs Revenue Market Share by Region (2021–2026)
 Table 23. Global Targeted Chemotherapy Drugs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Targeted Chemotherapy Drugs Revenue Market Share by Region (2027–2032)
 Table 25. North America Targeted Chemotherapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Targeted Chemotherapy Drugs Sales by Country (K Units), 2021–2026
 Table 27. North America Targeted Chemotherapy Drugs Sales by Country (K Units), 2027–2032
 Table 28. North America Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Targeted Chemotherapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Targeted Chemotherapy Drugs Sales by Country (K Units), 2021–2026
 Table 32. Europe Targeted Chemotherapy Drugs Sales by Country (K Units), 2027–2032
 Table 33. Europe Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Targeted Chemotherapy Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Targeted Chemotherapy Drugs Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Targeted Chemotherapy Drugs Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Targeted Chemotherapy Drugs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Targeted Chemotherapy Drugs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Targeted Chemotherapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Targeted Chemotherapy Drugs Sales by Country (K Units), 2021–2026
 Table 42. Latin America Targeted Chemotherapy Drugs Sales by Country (K Units), 2027–2032
 Table 43. Latin America Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Targeted Chemotherapy Drugs Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Targeted Chemotherapy Drugs Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Targeted Chemotherapy Drugs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Targeted Chemotherapy Drugs Sales (K Units) by Type (2021–2026)
 Table 51. Global Targeted Chemotherapy Drugs Sales (K Units) by Type (2027–2032)
 Table 52. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2021–2026)
 Table 53. Global Targeted Chemotherapy Drugs Sales Market Share by Type (2027–2032)
 Table 54. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2021–2026)
 Table 57. Global Targeted Chemotherapy Drugs Revenue Market Share by Type (2027–2032)
 Table 58. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Targeted Chemotherapy Drugs Sales (K Units) by Application (2021–2026)
 Table 61. Global Targeted Chemotherapy Drugs Sales (K Units) by Application (2027–2032)
 Table 62. Global Targeted Chemotherapy Drugs Sales Market Share by Application (2021–2026)
 Table 63. Global Targeted Chemotherapy Drugs Sales Market Share by Application (2027–2032)
 Table 64. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Targeted Chemotherapy Drugs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2021–2026)
 Table 67. Global Targeted Chemotherapy Drugs Revenue Market Share by Application (2027–2032)
 Table 68. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Application (2027–2032)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Roche Targeted Chemotherapy Drugs Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Celgene Company Information
 Table 76. Celgene Description and Business Overview
 Table 77. Celgene Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Celgene Targeted Chemotherapy Drugs Product
 Table 79. Celgene Recent Developments/Updates
 Table 80. Bristol-Myers Squibb Company Information
 Table 81. Bristol-Myers Squibb Description and Business Overview
 Table 82. Bristol-Myers Squibb Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Bristol-Myers Squibb Targeted Chemotherapy Drugs Product
 Table 84. Bristol-Myers Squibb Recent Developments/Updates
 Table 85. Takeda Company Information
 Table 86. Takeda Description and Business Overview
 Table 87. Takeda Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Takeda Targeted Chemotherapy Drugs Product
 Table 89. Takeda Recent Developments/Updates
 Table 90. Seekyo Company Information
 Table 91. Seekyo Description and Business Overview
 Table 92. Seekyo Targeted Chemotherapy Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Seekyo Targeted Chemotherapy Drugs Product
 Table 94. Seekyo Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Targeted Chemotherapy Drugs Distributors List
 Table 98. Targeted Chemotherapy Drugs Customers List
 Table 99. Targeted Chemotherapy Drugs Market Trends
 Table 100. Targeted Chemotherapy Drugs Market Drivers
 Table 101. Targeted Chemotherapy Drugs Market Challenges
 Table 102. Targeted Chemotherapy Drugs Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Targeted Chemotherapy Drugs
 Figure 2. Global Targeted Chemotherapy Drugs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Targeted Chemotherapy Drugs Market Share by Type: 2025 & 2032
 Figure 4. Monoclonal Antibodies (MABs) Product Picture
 Figure 5. Cancer Growth Blockers Product Picture
 Figure 6. Angiogenesis Inhibitors Product Picture
 Figure 7. PARP Inhibitors Product Picture
 Figure 8. Global Targeted Chemotherapy Drugs Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global Targeted Chemotherapy Drugs Market Share by Application: 2025 & 2032
 Figure 10. Breast Cancer Treatment
 Figure 11. Lung Cancer Treatment
 Figure 12. Gastric Cancer Treatment
 Figure 13. Others
 Figure 14. Global Targeted Chemotherapy Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Targeted Chemotherapy Drugs Market Size (US$ Million), 2021–2032
 Figure 16. Global Targeted Chemotherapy Drugs Sales (K Units), 2021–2032
 Figure 17. Global Targeted Chemotherapy Drugs Average Price (US$/Unit), 2021–2032
 Figure 18. Targeted Chemotherapy Drugs Report Years Considered
 Figure 19. Targeted Chemotherapy Drugs Sales Share by Manufacturers in 2025
 Figure 20. Global Targeted Chemotherapy Drugs Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Targeted Chemotherapy Drugs Players: Market Share by Revenue in Targeted Chemotherapy Drugs in 2025
 Figure 22. Targeted Chemotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Targeted Chemotherapy Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Targeted Chemotherapy Drugs Sales Market Share by Country (2021–2032)
 Figure 25. North America Targeted Chemotherapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 26. United States Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Targeted Chemotherapy Drugs Sales Market Share by Country (2021–2032)
 Figure 29. Europe Targeted Chemotherapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Targeted Chemotherapy Drugs Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Targeted Chemotherapy Drugs Revenue Market Share by Region (2021–2032)
 Figure 37. China Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America Targeted Chemotherapy Drugs Sales Market Share by Country (2021–2032)
 Figure 45. Latin America Targeted Chemotherapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Targeted Chemotherapy Drugs Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Targeted Chemotherapy Drugs Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE Targeted Chemotherapy Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Targeted Chemotherapy Drugs by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Targeted Chemotherapy Drugs by Type (2021–2032)
 Figure 57. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Targeted Chemotherapy Drugs by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Targeted Chemotherapy Drugs by Application (2021–2032)
 Figure 60. Global Targeted Chemotherapy Drugs Price (US$/Unit) by Application (2021–2032)
 Figure 61. Targeted Chemotherapy Drugs Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Targeted Oncology Drugs Market Research Report 2024
Global Cancer Targeted Drug Market Research Report 2025
Global Targeted Cancer Therapy Market Research Report 2024
Global Targeted Small Molecule Drug Market Research Report 2025
Global Personalized Cancer Medicine Market Research Report 2025
Global Cancer Targeted Small Molecule Therapy Market Research Report 2025
Global Targeted Small Molecule Therapy Market Research Report 2025
Global Anticancer Drugs Market Research Report 2025
Global Precision Cancer Medicine Market Research Report 2024
Global Oncology Targeted Therapy Market Research Report 2025
Global Targeted Antitumor Drugs Market Research Report 2025
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Global Chemotherapy Drug Market Insights Forecast to 2030
Global Targeted Radiotherapy Drug Market Research Report 2024
Global Leukemia Targeted Therapy Drugs Market Research Report 2024
Cancer Treatment Drugs Market
Global Oncology Injection Drug Market Research Report 2025
Global Small Molecule Targeted Cancer Therapy Market Research Report 2025
Molecular Targeted Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Monoclonal Antibody Drugs for Cancer Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions